Prognostic significance of diabetes and stress hyperglycemia in acute stroke patients

[1]  Weilei He,et al.  The Stress Hyperglycemia Ratio is Associated with Hemorrhagic Transformation in Patients with Acute Ischemic Stroke , 2021, Clinical interventions in aging.

[2]  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. , 2020, Diabetes care.

[3]  Hao Li,et al.  Effect of Stress Hyperglycemia on Neurological Deficit and Mortality in the Acute Ischemic Stroke People With and Without Diabetes , 2020, Frontiers in Neurology.

[4]  G. Gigli,et al.  Stress hyperglycemia is predictive of worse outcome in patients with acute ischemic stroke undergoing intravenous thrombolysis , 2020, Journal of Thrombosis and Thrombolysis.

[5]  C. Khoo,et al.  Stress Hyperglycaemia is Associated with Poor Functional Outcomes in Patients with Acute Ischaemic Stroke after Intravenous Thrombolysis. , 2020, QJM : monthly journal of the Association of Physicians.

[6]  M. Zoli,et al.  Predicting hemorrhagic transformation and its timing from maximum cerebral lesion diameter in nonlacunar ischemic strokes , 2019, Brain and behavior.

[7]  W. Powers,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. , 2019, Stroke.

[8]  Yilong Wang,et al.  Stress Hyperglycemia and Outcome of Non-diabetic Patients After Acute Ischemic Stroke , 2019, Front. Neurol..

[9]  Xingyu Chen,et al.  High Stress Hyperglycemia Ratio Predicts Poor Outcome after Mechanical Thrombectomy for Ischemic Stroke. , 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[10]  M. Gonthier,et al.  Hyperglycemia modulates redox, inflammatory and vasoactive markers through specific signaling pathways in cerebral endothelial cells: Insights on insulin protective action , 2019, Free radical biology & medicine.

[11]  A. Sabri,et al.  Hyperglycemia-Driven Neuroinflammation Compromises BBB Leading to Memory Loss in Both Diabetes Mellitus (DM) Type 1 and Type 2 Mouse Models , 2018, Molecular Neurobiology.

[12]  S. Johnston,et al.  Stress Hyperglycemia and Prognosis of Minor Ischemic Stroke and Transient Ischemic Attack: The CHANCE Study (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events) , 2017, Stroke.

[13]  Wen-I Liao,et al.  Usefulness of glycated hemoglobin A1c‐based adjusted glycemic variables in diabetic patients presenting with acute ischemic stroke , 2017, The American journal of emergency medicine.

[14]  A. Hatzitolios,et al.  Stress hyperglycemia and acute ischemic stroke in-hospital outcome. , 2017, Metabolism: clinical and experimental.

[15]  I. Dégano,et al.  Glycated Hemoglobin Value Combined with Initial Glucose Levels for Evaluating Mortality Risk in Patients with Ischemic Stroke , 2015, Cerebrovascular Diseases.

[16]  S. Davis,et al.  Acute effects of hyperinsulinemia and hyperglycemia on vascular inflammatory biomarkers and endothelial function in overweight and obese humans. , 2015, American journal of physiology. Endocrinology and metabolism.

[17]  J. Rafols,et al.  Hyperglycemia in stroke and possible treatments , 2013, Neurological research.

[18]  A. Leger,et al.  Intensive Versus Subcutaneous Insulin in Patients With Hyperacute Stroke: Results From the Randomized INSULINFARCT Trial , 2012, Stroke.

[19]  G. Umpierrez,et al.  Oxidative stress and inflammation in hyperglycemic crises and resolution with insulin: implications for the acute and chronic complications of hyperglycemia. , 2012, Journal of diabetes and its complications.

[20]  D. Nathan,et al.  International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.

[21]  J. Shaw,et al.  International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.

[22]  K. Lees,et al.  Hyperglycaemia in Acute Stroke – To Treat or Not to Treat , 2009, Cerebrovascular Diseases.

[23]  B. Göke,et al.  Serum concentrations of cortisol, interleukin 6, leptin and adiponectin predict stress induced insulin resistance in acute inflammatory reactions , 2008, Critical care.

[24]  M. Lorenzo,et al.  Insulin resistance induced by tumor necrosis factor-α in myocytes and brown adipocytes , 2008 .

[25]  P. Sandercock,et al.  Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK) , 2007, The Lancet Neurology.

[26]  Qing Wang,et al.  The inflammatory response in stroke , 2007, Journal of Neuroimmunology.

[27]  A. Tuttolomondo,et al.  Risk factors profile and clinical outcome of ischemic stroke patients admitted in a Department of Internal Medicine and classified by TOAST classification. , 2006, International angiology : a journal of the International Union of Angiology.

[28]  J. Gaughan,et al.  Decreased mortality by normalizing blood glucose after acute ischemic stroke. , 2006, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[29]  F. Vancheri,et al.  Impaired glucose metabolism in patients with acute stroke and no previous diagnosis of diabetes mellitus. , 2005, QJM : monthly journal of the Association of Physicians.

[30]  K. Butcher,et al.  Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. , 2003, Stroke.

[31]  H. Gerstein,et al.  Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview , 2001, Stroke.

[32]  J. Marler,et al.  Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators. , 1999, Stroke.

[33]  L Bozzao,et al.  Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. , 1999, Stroke.

[34]  J. Kolls,et al.  An in Vivo Model for Elucidation of the Mechanism of Tumor Necrosis Factor-α (TNF-α)-Induced Insulin Resistance: Evidence for Differential Regulation of Insulin Signaling by TNF-α. , 1998, Endocrinology.

[35]  G. Murray,et al.  Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study , 1997, BMJ.

[36]  B. Spiegelman,et al.  Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. , 1994, The Journal of clinical investigation.

[37]  R. Stout,et al.  Hyperglycaemia and mortality from acute stroke. , 1994, The Quarterly journal of medicine.

[38]  P. Koudstaal,et al.  Hyperglycemia in the Acute Phase of Stroke Is Not Caused by Stress , 1993, Stroke.

[39]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[40]  J. Bamford,et al.  Classification and natural history of clinically identifiable subtypes of cerebral infarction , 1991, The Lancet.

[41]  M. Zorzon,et al.  Hyperglycemia at ischemic stroke onset as prognostic factor , 1991, The Italian Journal of Neurological Sciences.

[42]  J. Woo,et al.  The influence of hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. , 1990, Archives of neurology.

[43]  J. Rankin.  Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis , 1957, Scottish medical journal.

[44]  S. Tokuyama,et al.  Ischemic Stroke and Glucose Intolerance: a Review of the Evidence and Exploration of Novel Therapeutic Targets. , 2012, Journal of pharmacological sciences.

[45]  M. Lorenzo,et al.  Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes. , 2008, Journal of animal science.

[46]  V. V. Solter,et al.  Impact of hyperglycemia on ischemic stroke mortality in diabetic and non-diabetic patients , 2007, Annals of Saudi medicine.

[47]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[48]  J. Kolls,et al.  An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha. , 1998, Endocrinology.